Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > $$$$$$$

<< Previous

Bullboard Posts

Next >>

Comment by venture009on Aug 30, 2024 7:29pm

67 Views

Post# 36203592

RE:RE:RE:RE:RE:$$$$$$$

After 4 years of nonsense created by the likes of H. Clinton and other Democrats like Pelosi ripping up his State of the Union speech and now the ridiculous DOJ overreach it's not much wonder he is calling people names. In most cases his descriptions are accurate.  

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project